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Objective: This review is a narrative synthesis of the RCTs which studied the efﬁcacy of using diagnostic
tests to reassure patients.
Methods: We searched for RCTs that examined the level of reassurance after diagnostic testing in
outpatients. We used PubMed, Psychinfo, Cochrane Central, Ongoing Trials Database and Scopus.
Results: We found 5 randomized controlled trials that included 1544 patients. The trials used different
diagnostic tests (ECG, radiography of lumbar spine, MR brain scan, laboratory tests, MR of lumbar spine)
for different complaints (e.g. chest pain, low back pain and headache). Four out of 5 RCTs did not ﬁnd a
signiﬁcant reassuring value of the diagnostic tests. One study reported a reassuring effect at 3 months
which had disappeared after one year.
Conclusion: Despite the sparse and heterogeneous studies, the results point in the direction of diagnostic
tests making hardly any contribution to the level of reassurance. We recommend further studies on the
use of diagnostic tests and other strategies to reassure the patient.
Practice implications: A clear explanation and watchful waiting can make additional diagnostic testing
unnecessary. If diagnostic tests are used, it is important to provide adequate pre-test information about
normal test results.
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1. Introduction
According to the Oxford Dictionary of English, reassurance is
‘the action of removing someone’s doubts or fears’. Providing
reassurance is one of the most important tasks of GPs [1]. Patients
often fear that something serious is wrong and expect to be
reassured by their physician [2]. Physicians have several strategies
for reassuring their patients: paying sincere attention by listening
well, explaining medical terminology in comprehensible language
and ‘laying hands’ during physical examination [3]. Another way of
reassuring the patient is making use of diagnostic tests.
The use of diagnostic tests for reassurance of the patient is
considerable in family practice. In a Dutch cohort study in primary
care (n = 31,000) the reasons for requesting diagnostic tests were
recorded over a one year period. Of all requested diagnostic tests,
reassurance of the patient was the fourth reason for ordering tests,
in 11% of the requests it was the main reason for testing [4]. This
percentage might be lower than in other countries, regarding the
fact that Dutch family practitioners are not paid for ordering tests.
Despite the apparent conﬁdence of physicians in the reassuring
value of diagnostic tests, the effects remain doubtful. For example,
in 40 replicated single case studies McDonald et al. [5] examined
whether normal test results reduce patients’ fears. Patients were
referred for echocardiography, in 10 cases because of symptoms
and in 30 cases because of a heart murmur. All but one had normal
test results. The patients presenting with symptoms were all left
with worries despite a normal test result. Of the patients with a
heart murmur, 20 became anxious after the detection of the
murmur; 11 had residual worries despite the normal test result.
Thus, negative test results are not always effective in reassuring
patients.
We performed a systematic review of randomized controlled
trials assessing the reassuring value of diagnostic tests, both in
primary care and outpatient secondary care settings. As there is no
generally accepted instrument to measure the level of reassurance,
we accepted different instruments for the measurement of
reassurance. We included various diagnostic tests, therefore we
did not expect that we would be able to perform a meta-analysis.
Our goal was to give a narrative synthesis of the current evidence.
The effect of diagnostic tests on the level of reassurance is our
primary outcome. Furthermore, we assessed whether diagnostic
testing inﬂuenced symptom and disability levels and patient
satisfaction.
2. Methods
2.1. Selection criteria
In October 2009 we systematically searched for RCTs assessing
the reassuring properties of diagnostic tests. Our inclusion criteria
were: (1) type of study: RCT, (2) any diagnostic test, (3) subjects:
outpatients, (4) control condition: patients not receiving results of
a diagnostic test, and (5) outcome: level of reassurance.
2.2. Search methods
We searched in PubMed, Psychinfo, Cochrane Central, Ongoing
trials database and Scopus, which includes the Embase database.
For Pubmed, our search consisted of three parts, combined with the
Boolean operator AND: the text word ‘reassur*’, the string
‘Diagnostic Techniques and Procedures’ or ‘Laboratory Techniques
and Procedures’ (MeSH terms) and an established search string for
controlled trials (5). Repeating this search with other words
(‘consola*’, ‘relie*’, ‘comfor*’, and ‘alleviat*’) instead of reassur* did
not reveal additional publications. We adapted the searches for the
other databases as required. There was no language restriction.
2.3. Data collection
Three investigators (DD, PL, and HvR) independently included
publications from the list of retrieved publications by reading title
and abstract. When title and abstract did not reveal sufﬁcient
information for inclusion, the investigators read the whole
publication. After inclusion we checked the references for
additional publications. Subsequently, three investigators (DD,
HvR, and IvD) extracted and registered the data on standard forms.
Disagreements about in- or exclusion or data extraction were
resolved by consulting a fourth investigator (FvdL). Inter-
investigator agreement on in- and exclusion was calculated as
kappa; we considered kappa 0.6–0.8 as good, and kappa 0.8–1.0 as
excellent agreement [6]. Our primary outcome measure is the level
of reassurance. Secondary outcome measures are symptom levels,
disability levels and patient satisfaction.
2.4. Data analysis
Outcomes are described per study. We assessed whether there
was a difference in the level of reassurance between the test group
and the control group. For the evaluation of the risk of bias we
(HvR, PL, and IvD) assessed the randomization procedure,
allocation concealment, the drop-out rate and blinding of the
outcome assessor. Two reviewers assessed each trial indepen-
dently. Patient and physician blinding was not a part of the
assessment, because in this type of studies blinding is practically
impossible.
3. Results
The searches yielded 4602 different publications to be judged
for in- and exclusion. We included 6 journal articles that described
4 different randomized controlled trials [7–12]. The kappa for in-
and exclusion was 0.80 (CI 0.77–0.83). One additional study
resulted from checking references [13]. In sum, we present the
results of 5 RCTs of in total 7 articles on the reassuring effect of
diagnostic tests (Fig. 1). In Table 1 study details are provided. The
trials were published between 1981 and 2009.
Records id enﬁed Addional records
through dat abase
searching
(n=4794)
idenﬁ ed through
other sou rces
(n=1)
Records a er dupli cates
removed
(n=4602)
Records sc reene d
(n=4603)
Records exclud ed
(n=4585)
Full-text arcles ass ess ed for eli gibility
(n=18)
Full text arcles
excluded: no  ulﬁlling
inclusion cri teria
(n=13)
Studies included in na rrave synth esis
(n=5)
Fig. 1. Flowchart of study inclusion.
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Table 1
Characteristics of RCT’s which measure the reassuring value of diagnostic tests.
Source Type of
complaint
Inclusion criteria Diagnostic
test group
Control group Setting Patients
intervention/
control (n= )
Measure for
reassurance
Baseline level of
reassurance or
worry
Follow up level of
reassurance or worry
Direction of effects
Sox et al.
[13]
Chest pain Chief symptom is
chest pain, with
low risk of having
ischemic pain
ECG and
laboratory
tests
Care as usual Outpatient
clinic
74/72 5-Point scale:
worry that the
pain was due to
serious disease
67% of patients in
the test group and
70% of patients in
the control group
worried
20% of patients in both
groups worried
(2 months); 16% of
patients receiving tests
and 22% in the control
group worried
(4 months)
No signiﬁcant
difference between
groups at 2 and 4
months (p>0.02)
Miller et al.
[7]
Low back
pain
Pain for at least
6 weeks, or at
randomization
and >6 weeks in
past 6 months
Radiography
of lumbar
spine
Care as usual Primary care
practices
195/199 5-Point scale:
reassurance that
there is no serious
condition causing
the pain
44% of patients in
the test group and
47% of patients in
the control group
felt reassured
58% of patients in the
test group were
reassured, 48% of
patients in the control
group were reassured
No signiﬁcant
difference between
groups at 9 months
(p=0.37)
Howard
et al. [10]
Headache Headache at least
15days a month
for >6 months
MRI brain
scan
Care as usual Outpatient
clinic
71/71 VAS: level of worry
about health +5-point
scale: something
seriously wrong
causing the pain
(0–100 maximal
worry)
Mean score on VAS
in test group 60
(SD 32) and in
control group 69
(SD 25); no
information
available
about scores on
5-point scale
Mean score on VAS 43
in both groups at one
year; on 5-point scale:
patients in test group
less worried about
serious cause at 3
months (no exact data),
no difference at 1 year
Signiﬁcant difference
at 3 months, patients
in test group have less
fear for something
serious (p=0.004); no
signiﬁcant difference
at one year in 5-point
scale, nor in VAS
scores
Ash et al.
[11]
Low back
pain and/or
radiculopathy
Low back pain
and/or
radiculopathy
for <3 weeks;
age 18–65 years
MRI of
lumbar
spine
MRI of lumbar
spine, patient
and physician
blinded to
results until
6 months after
scan
Primary care
and secondary
care (with
outpatients)
115/131 Fear avoidance
questionnaire24:
4 items on beliefs
about physical
activity (0–24
maximal avoidance)
Mean score in test
group 17.0 (SD 5.8)
and in control
group 17.4
(SD 5.5)
Mean score in test
group 13.8 (SD 6.4) and
in control group 13.4
(SD 6.3) at 6 weeks;
mean score in test
group 13.3 (SD 7.0)
and in control group
13.9 (SD 6.5) at one
year
No signiﬁcant
differences between
groups at 6 weeks
(p=0.70), nor at
1 year (p=0.59)
van Bokhoven
et al. [12]
Fatigue,
abdominal
complaints,
musculoskeletal
complaints,
weight change,
or pruritus
Complaint
remained
unexplained after
history taking
and physical
examination;
blood test might
add to the
diagnosis;
age 18 years
or older
Laboratory
blood tests
Watchful
waiting
(with or
without
quality
improvement
education)
Primary care
practices
229/269 10-point scale: level
of anxiety (0–10)
maximal anxiety
No baseline
measures were
taken
Mean score in test
group 3.1 (SD 2.5),
mean score in control
group 3.0 (SD 2.8)
No signiﬁcant
difference between
groups after the
consultation
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The included trials measured the reassuring effect of ﬁve
different diagnostic tests, or combinations of tests: ECG and
laboratory blood tests for chest pain, radiography of the lumbar
spine for low back pain, MR brain scan for headache, laboratory
blood tests for 5 speciﬁed unexplained complaints and one trial
studied the reassuring effects of MR for low back pain. Most trials
compared the reassuring effects of a diagnostic test with a control
group without diagnostic tests [7,10,12,13]. In the study by Ash
et al. [11] all patients were provided with a diagnostic test, both
patients in the intervention group and in the control group
received an MR scan. However, the patients and physicians in the
control group did not receive the results of the MR scan until six
months after the scan. The total number of patients that have been
studied in the included trials is 1544. Two trials have been
performed in the United States of America [11,13], two trials in the
United Kingdom [7,10] and one trial in the Netherlands [12]. Three
trials use a similar deﬁnition of reassurance: taking away the
concern that something serious is wrong [7,10,13]. Ash et al. and
van Bokhoven et al. deﬁned reassurance by the absence of anxiety.
They asked for the current anxiety level [12] and the anxiety level
concerning the current and future physical situation [11].
Quality assessment details are provided in Table 2. Four out of
ﬁve studies had adequate randomization and allocation conceal-
ment procedures. In the study by Sox et al. the procedures are not
mentioned. All studies, except for the study by van Bokhoven et al.,
have high dropout rates: between 16 and 77%. Blinding during
outcome assessment was described in only one trial, the trial by
Howard et al.
3.1. Reassurance levels
None of the trials found a signiﬁcant difference in reassurance
levels between intervention and control group at the end of the
follow up. One trial, the study by Howard et al., did ﬁnd a
signiﬁcantly higher reassurance level in the intervention group at 3
months (p = 0.004), but not at 12 months. Trials which measured
the level of reassurance (or worry) both at baseline and at follow
up, all show that with the passing time the level of worry decreases
[7,10,11,13]
3.2. Symptom levels
Symptom levels have been measured in four trials
[7,10,11,13]. Two trials did not ﬁnd a signiﬁcant difference in
symptom levels between the intervention and control group
[11,13]. One study shows that 3 months after randomization the
percentage of patients that still experienced back pain was
higher in the radiography group than in the control group, 74%
versus 65% (p = 0.04). At nine months there was no signiﬁcant
difference between intervention and control group [7]. In
another trial the subgroup of patients with high scores on
anxiety and depression at baseline had signiﬁcantly less
headaches after receiving an MR scan, than the patients who
had not received an MR scan at one year follow up. Patients
without anxiety and depression at baseline did not show a
difference in symptom levels between intervention and control
condition [7,10,11,13].
3.3. Disability levels
In three trials the disability levels have been measured
[7,11,13]. The study by Ash et al. measured self-rated disability
due to back pain, no signiﬁcant differences between the groups
were found. Another trial found a signiﬁcant difference in
disability levels at three months follow-up; patients that were
assigned to diagnostic testing, reported higher disability scores
compared to the control group [7]. However, there was no
signiﬁcant difference at the end of follow up, at 9 months. The only
study which found lower disability levels in the intervention group
is the study by Sox et al. Disability was measured by asking
whether the activity level was unchanged or less than at the index
visit. At 3 weeks follow up 46% of the control group reported
disability, whereas in the intervention group 20% of the patients
reported disability (p < 0.01). At four months follow up the
difference had disappeared.
3.4. Patient satisfaction
Patient satisfaction was measured in three trials [7,12,13].
One did not ﬁnd any difference between the groups [12]. In the
trial by Miller et al. at nine months follow up the patients who
received a radiography were more satisﬁed with care than the
controls (p < 0.01). Sox et al. found a short term difference: at 3
weeks follow up 57% of the patients in the intervention group
were satisﬁed with care versus 31% in the control group
(p < 0.0001). At 4 months there was no difference between the
groups.
4. Discussion and conclusion
Although the use of diagnostic tests to reassure patients is
common [4], we identiﬁed only ﬁve randomized controlled trials
which could be included in our systematic review. None of these
trials found a signiﬁcant difference in reassurance levels between
intervention and control group at the end of the follow up. We did
ﬁnd an increase in reassurance over time, but this was irrespective
of whether participants had the diagnostic test (intervention
group) or not (control group).
Table 2
Quality assessment of RCT’s on the reassuring value of diagnostic tests.
Study Adequate
randomization
Adequate allocation
concealment
Adequate drop out handling:
description of drop outs and
dropout rate (<15%)
Blinding during outcome assessment
Sox et al. (1981) No: procedure
not mentioned
No: not mentioned No: insufﬁcient description
and drop out 16%
Not mentioned
Miller et al. (2002) Yes: computer
generated scheme
Yes: sealed opaque
envelope
No: clear description, but total
dropout rate 77% (at reassurance
level measurement)
No: outcome assessor was not blinded
for the intervention
Howard et al. (2005) Yes: computer
generated scheme
Yes: sealed envelope No: clear description, but dropout
rate 36%
Yes: outcome assessor was blind to
intervention
Ash et al. (2008) Yes: stratiﬁed
block design
Yes: concealed envelope No: insufﬁcient description and
dropout rate at 3 months 28%
Not mentioned
van Bokhoven
et al. (2009)
Yes: computer
generated list
Not applicable, practices
were randomized as a
whole
Yes: clear description and total
dropout rate 3%
No: outcome assessor was not blinded
for the intervention
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4.1. Strengths and limitations
4.1.1. Strengths
Our extensive and thorough search in all relevant databases
without language restriction and the selection of studies by two
independent researchers make it unlikely that we missed relevant
studies. Moreover, we had excellent interrater agreement (kappa
0.80) for in- and exclusion. Finally, two independent researchers
extracted the data and assessed the quality of included studies
with a validated checklist. In scientiﬁc literature the concept
‘reassurance’ has not yet been clearly articulated, therefore we
used the deﬁnition of the Oxford dictionary of English. Our
conceptualization of ‘reassurance’ as ‘the action of removing
someone’s doubts or fears’ was similar to the deﬁnitions which
were used in the included RCT’s.
4.1.2. Limitations
The small number of trials and the relatively low methodologi-
cal quality of the included trials do not permit us to draw ﬁrm
conclusions about the reassuring value of diagnostic tests. We
found a high heterogeneity of instruments used to measure
reassurance levels. Moreover, most trials used non-validated
questionnaires. Due to the diversity among the measurement
instruments, the diversity among medical conditions in the trials
and the consequent diversity in diagnostic tests, we cannot make
any statement about the reassuring properties of a speciﬁc
diagnostic test. For the same reasons we could not perform a
meta-analysis.
4.2. Considerations for clinical practice
There is a widely shared belief in clinical practice that patients
will be reassured after additional testing. Physicians might heavily
rely on the supposed reassuring effect of a normal test result,
whereas patients might not share the implications of this. In this
review we could not conﬁrm this supposed reassuring effect of
diagnostic testing. On the contrary, the application of diagnostic
testing could also increase worrying as it might unintentionally
conﬁrm the patient’s conviction that the symptoms are serious
[14,15]. For example, in a qualitative study by Donovan and Blake
[16] the investigators concluded that the typical methods of
providing reassurance – allaying fears and anxieties by emphasiz-
ing the minor seriousness or early stage of a disease – are not
necessarily interpreted as reassuring by patients. For patients who
previously did not worry about their health ordering a diagnostic
test can be a cause of anxiety itself [5]. However, we did not ﬁnd an
increase of worrying after diagnostic testing in our systematic
review.
The diagnostic tests in the trials in this review have been
targeted to the medical conditions to be studied and not to
associated individual fears and worries. Concerning the quality and
amount of information given by the physician before ordering the
test, Petrie et al. found out that patients who received good pre-test
information were signiﬁcantly more likely to be reassured after the
test than patients who did not receive this information [17]. It is
not difﬁcult to imagine that a good doctor–patient relationship
increases the sense of reassurance of the patient: the patient ﬁnds a
good listener, a person who gives a clear explanation and who is
committed to caring over time [18]. van Bokhoven et al. [12] found
that reassurance and patient satisfaction had a stronger associa-
tion with the quality of the doctor–patient relationship in general,
than with ordering of diagnostic tests. The reassuring value of
diagnostic testing depends on how well the diagnostic test
matches with disclosed worries and fears of the patient, on the
information provided by the physician about the consequences of a
positive or negative test result, and on the quality of the doctor-
patient relationship. Therefore, no ﬁrm conclusions about a
reassuring value of diagnostic testing can be made when the
individual fears, the pre-test information and the doctor–patient
relation are not taken into account. Future research about the
reassuring value of diagnostic testing should deal with these
factors.
4.3. Conclusion
There is a lack of sound methodological studies about the
reassuring value of diagnostic tests. More trials are needed to judge
the efﬁcacy of speciﬁc diagnostic tests in providing reassurance. It
would be wise to use validated questionnaires for the measure-
ment of reassurance. There is very limited evidence for the
assumption that diagnostic tests intrinsically reassure patients.
4.4. Practice implications
In clinical practice we advice an early exploration of the
patient’s fears. By making them explicit, they can be discussed and
an explanation about the symptom can be given. Watchful waiting
can sometimes make diagnostic testing unnecessary. If diagnostic
tests are used, it is important to provide adequate pre-test
information about normal test results. Diagnostic tests are easily
available and might seem to be a good instrument to reassure
patients, but this review shows that the reassuring effect of
diagnostic tests is limited.
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